Our research demonstrates that hyperglycemia-induced mitochondrial dysfunction, especially characterized by impaired PINK1-Parkin-dependent mitophagy, is significantly mitigated by canagliflozin treatment. This evidence concerns the gene PRKN and Hyperglycemia.